Nodular amiodarone lung disease

American Journal of Surgical Pathology

Volumn 32, Issue 11, 2008, Pages 1654-1660

  Ruangchira Urai, Ruchira ^a,c   Colby, Thomas V ^b   Klein, Julianne ^d   Nielsen, G Petur ^a   Kradin, Richard L ^a   Mark, Eugene J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Amiodarone; Drug pneumonitis

Indexed keywords

AMIODARONE; CORTICOSTEROID DERIVATIVE; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN G; WARFARIN; ANTIARRHYTHMIC AGENT;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; GUILLAIN BARRE SYNDROME; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUNG ABSCESS; LUNG BIOPSY; LUNG CANCER; LUNG EXAMINATION; LUNG NODULE; MALE; NEUROPATHY; POLYRADICULONEUROPATHY; PULMONARY VASCULITIS; CELL INCLUSION; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; HISTIOCYTE; LUNG DISEASE; MIDDLE AGED; PATHOLOGY; VASCULITIS;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTES; HUMANS; INCLUSION BODIES; LUNG ABSCESS; LUNG DISEASES; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; VASCULITIS;

EID: 56149127253     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31816d1cbc     Document Type: Article

References (34)

1. Anderson N, Borlak J. Drug-induced phospholipidosis. FEBS Lett. 2006;580:5533-5540.
2. Arnon R, Raz I, Chajek-Shaul T, et al. Amiodarone pulmonary toxicity presenting as a solitary lung mass. Chest. 1988;93:425-427.
3. Azzam I, Tov N, Elias N, et al. Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge. Postgrad Med J. 2006;82:73-75.
4. Chandhok S, Schwartzman D. Amiodarone therapy for atrial rhythm control: insights gained from a single center experience. J Cardiovasc Electrophysiol. 2007;18:714-718.
5. Chouri N, Langin T, Lantuejoul S, et al. Pulmonary nodules with the CT halo sign. Respiration. 2002;69:103-106.
6. Connolly SJ, Cairns JA, Gent M, et al. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials. Lancet. 1997;350:1417-1424.
7. Dean PJ, Groshart KD, Porterfield JG, et al. Amiodaroneassociated pulmonary toxicity. A clinical and pathologic study of eleven cases. Am J Clin Pathol. 1987;87:7-13.
8. Inampudi P, Gross BH, Tankanow LB. Lung masses in a 70-year-old man. Chest. 2005;127:1433-1436.
9. Iskandar SB, Abi-Saleh B, Keith RL, et al. Amiodarone-induced alveolar hemorrhage. South Med J. 2006;99:383-387.
10. Jarand J, Lee A, Leigh R. Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity. CMAJ. 2007;176: 1411-1413.
11. Kaufmann P, Török M, Hänni A, et al. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology. 2005;41: 925-935.
12. Kaushik S, Hussain A, Clarke P, et al.. Acute pulmonary toxicity after low-dose amiodarone therapy. Ann Thorac Surg. 2001;72: 1760-1761.
13. Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol. 2002;89:896-898.
14. Kuhlman JE, Teigen C, Ren H, et al. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology. 1990;177: 121-125.
15. Martin WJ II, Rosenow EC III. Amiodarone pulmonary toxicity. Recognition and pathogenesis (part I). Chest. 1988;93:1067-1075.
16. Myers JL, Kennedy JI, Plumb VJ. Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol. 1987;18:349-354.
17. Nicolet-Chatelain G, Prevost MC, Escamilla R, et al. Amiodaroneinduced pulmonary toxicity. Immunoallergologic tests and bronch-oalveolar lavage phospholipids content. Chest. 1991;99:363-369.
18. Okayasu K, Takeda Y, Kojima J, et al. Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. Intern Med. 2006;45:1303-1307.
19. Olshansky B, Sami M, Rubin A, et al. Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM Study. Am J Cardiol. 2005;95:404-405.
20. Omeroglu G, Kalugina Y, Ersahin C, et al. Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fineneedle aspiration: cytologic, histologic, and electron microscopic findings. Diagn Cytopathol. 2006;34:351-354.
21. Ott MC, Khoor A, Leventhal JP, et al. Pulmonary toxicity in Patients receiving low-dose amiodarone. Chest. 2003;123:646-651.
22. Piazza I, Bizzaro N. A localized pleuropulmonary lesion induced by long-term therapy with amiodarone. Respiration. 1992;59:185-188.
23. Piccione W Jr, Faber LP, Rosenberg MS. Amiodarone-induced pulmonary mass. Ann Thorac Surg. 1989;47:918-919.
24. Pirovino M, Muller O, Zysset T, et al. Amiodarone-induced hepatic phospholipidosis: correlation of morphological and biochemical findings in an animal model. Hepatology. 1988;8:591-598.
25. Polkey MI, Wilson PO, Rees PJ. Amiodarone pneumonitis: no safe dose. Respir Med. 1995;89:233-235.
26. Pollak PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol. 1999;84: 37R-45R.
27. Reyes CV, Thompson KS, Jensen J. Multivesiculated macrophages: their implication in fine-needle aspiration cytology of lung mass lesions. Diagn Cytopathol. 1998;19:98-101.
28. Rodríguez-García JL, García-Nieto JC, Ballesta F, et al. Pulmonary mass and multiple lung nodules mimicking a lung neoplasm as amiodarone-induced pulmonary toxicity. Eur J Intern Med. 2001;12: 372-376.
29. Scharf C, Oechslin EN, Salomon F, et al. Clinical picture: amiodarone-induced pulmonary mass and cutaneous vasculitis. Lancet. 2001;358:2045.
30. Siddoway LA. Amiodarone: guidelines for use and monitoring. Am Fam Physician. 2003;68:2189-2196.
31. Singh S. Amiodarone-induced pulmonary hemorrhage. South Med J. 2006;99:329-330.
32. Spaniol M, Bracher R, Ha HR, et al. Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J Hepatol. 2001;35:628-636.
33. Valle JM, Alvarez D, Antunez J, et al. Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology. Eur Respir J. 1995;8:470-471.
34. Wood DL, Osborn MJ, Rooke J, et al. Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc. 1985;60:601-603.